How Do You Plan for the Death of a Spouse?
Beneficiary designations, tying up loose ends, reporting last wishes—here’s what you can do now.
Does Living Trust Help with Probate and Inheritance Taxes?
I was told that unlike wills, a trust doesn’t require probate and is not taxable. My main asset is a house that I want to pass on to my son. Would a living trust help?
Do You Know These Social Security Surprises?
Millions of seniors rely heavily on Social Security to make ends meet. If you're planning to do the same, you should know the ins and outs of how the program works.
Spring has Sprung. When Should I Start my Estate Plan? Now!
Spring has Sprung. When Should I Start my Estate Plan? Now! According to an article by MerchantsBank.com entitled: Guide to Estate Planning by Age, You might think estate planning doesn’t apply to you. You aren’t old enough. You don’t have…
Ashes in the Mail — Dealing with the Loss of a Loved One has Changed in the COVID Era
Ashes in the Mail -- Dealing with the Loss of a Loved One has Changed in the COVID Era Jason Oszczakiewicz, a Pennsylvania funeral home director known as "Oz," has become accustomed to delivering the ashes of recently deceased persons…
Can You Increase Your Social Security Benefits?
All you have to do is type ‘maximize Social Security’ into Google or any other search engine and you will get hundreds, if not thousands, of hits.
Get Estate Plan in Order, If Spouse Is Dying from a Terminal Illness
Planning for the death of a spouse is difficult and painful. It involves conversations that we don’t want to have.
Do Farmers Have a Higher Chance of Getting Dementia?
Those who held long-term jobs in agriculture, forestry and fishery had a 46% greater chance of having dementia.
What Is Status of Larry King’s Handwritten Will?
Larry King's handwritten will was recently obtained by outlets. It reportedly left out his estranged wife.
The Latest Treatments for Alzheimer’s Disease
Treatment for Alzheimer's disease, the devastating condition that affects more than five million Americans, has remained notoriously elusive for decades. Now, a small study released by drug company Eli Lilly offers at least a flicker of hope: It shows that the experimental drug donanemab may significantly slow patients’ cognitive decline.